lOMoAR cPSD| 28724214
TEST BANK Pharmacotherapeutics FOR Advanced Practice
4E TEST BANK
, lOMoAR cPSD| 28724214
Contents
Chapter 1 Issues for the Practitioner in Drug Therapy .............................. 3
Chapter 2.Pharmacokinetic Basis of Therapeutics and
Pharmacodynamic .......................................................................................... 5
Chapter 3. Impact of Drug Interactions and Adverse Events on
Therapeutics .................................................................................................. 13
Chapter 4. Principles of Pharmacotherapy in Children ........................... 18
Chapter 5. Principles of Pharmacotherapy in Pregnancy and Lactation
........................................................................................................................ 21
Chapter 6. Principles of Pharmacotherapy in Elderly Patients ............... 27
Chapter 7 Principles of Pharmacotherapy in Pain Management ............ 30
Chapter 8. Principles of Antimicrobial Therapy ....................................... 34
Chapter 9. Complementary and Alternative Medicines ........................... 39
Chapter 10. Pharmacogenomics .................................................................. 43
Chapter 11. Contact Dermatitis.................................................................. 46
Chapter 12. Fungal Infections of the Skin .................................................. 49
Chapter 13 Viral Infections of the Skin ...................................................... 53
Chapter 14 Bacterial Infections of the Skin ............................................... 54
Chapter 15. Psoriasis .................................................................................... 59
Chapter 16. Acne Vulgaris and Rosacea ..................................................... 61
Chapter 17 Ophthalmic Disorders .............................................................. 62
Chapter 18. Otitis Media/Externa ............................................................... 67
Chapter 19. Hypertension ............................................................................ 70
Chapter 20. Hyperlipidemia ........................................................................ 74
Chapter 21. Angina ...................................................................................... 78
Chapter 22. Heart Failure ............................................................................ 83
Chapter 23. Dysrhythmias ........................................................................... 87
Chapter 25. Asthma ..................................................................................... 94
Chapter 26. Chronic Obstructive Pulmonary Disease .............................. 97
Chapter 27. Bronchitis and Pneumonia...................................................... 98
Chapter 28. Nausea and Vomiting ........................................................... 101
, lOMoAR cPSD| 28724214
Chapter 29. Gastroesophageal Reflux Disease and Peptic Ulcer
Disease .......................................................................................................... 103
Chapter 30. Constipation Diarrhea and Irritable Bowel Syndrome ..... 107
Chapter 31 Inflammatory Bowel Disease ................................................. 109
Chapter 32. Urinary Tract Infections ....................................................... 111
Chapter 34. Overactive Bladder ................................................................ 114
Chapter 35. Sexually Transmitted Infections ........................................... 116
Chapter 36. Osteoarthritis and Rheumatoid Arthritis............................ 119
Chapter 37. Fibromyalgia .......................................................................... 121
Chapter 39 Seizure Disorders .................................................................... 127
Chapter 40. Depressive Disorders ............................................................. 131
Chapter 42 Insomnia and Sleep Disorders ............................................... 136
Chapter 43. Attention Deficit/Hyperactivity Disorder ............................ 137
Chapter 44. Alzheimer’s Disease .............................................................. 139
Chapter 45. Diabetes Mellitus.................................................................... 140
Chapter 46. Thyroid Disorders .................................................................. 148
Chapter 47. Allergies and Allergic Reactions ........................................... 152
Chapter 48. Human Immunodeficiency Virus ......................................... 155
Chapter 49. Coagulation Disturbances ..................................................... 158
Chapter 50. Anemias.................................................................................. 161
Chapter 51. Immunizations ....................................................................... 165
Chapter 52. Smoking Cessation................................................................. 169
Chapter 54. Weight Loss ............................................................................ 173
Chapter 55. Contraception......................................................................... 175
Chapter 56. Menopause and Menopausal Hormone Therapy ............... 178
Chapter 57. Osteoporosis ........................................................................... 180
Chapter 58 Vaginitis ................................................................................... 183
Chapter 59. The Economics of Pharmacotherapeutics ........................... 185
Chapter 60. Integrative Approaches to Pharmacotherapy – A look at
Complex Cases ............................................................................................ 189
, lOMoAR cPSD| 28724214
Chapter 1 Issues for the Practitioner in Drug Therapy
MULTIPLE CHOICE
1. Nurse practitioner prescriptive authority is regulated by:
A. The National Council of State Boards of Nursing
B. The U.S. Drug Enforcement Administration
C. The State Board of Nursing for each state
D. The State Board of Pharmacy
ANS: C PTS: 1
2. Physician Assistant (PA) prescriptive authority is regulated by:
A. The National Council of State Boards of Nursing
B. The U.S. Drug Enforcement Administration
C. The State Board of Nursing
D. The State Board of Medical Examiners
ANS: D PTS: 1
3. Clinical judgment in prescribing includes:
A. Factoring in the cost to the patient of the medication prescribed
B. Always prescribing the newest medication available for the disease process
C. Handing out drug samples to poor patients
D. Prescribing all generic medications to cut costs
ANS: A PTS: 1
4. Criteria for choosing an effective drug for a disorder include: A. Asking the
patient what drug they think would work best for them
B. Consulting nationally recognized guidelines for disease management
C. Prescribing medications that are available as samples before writing a
prescription
D. Following U.S. Drug Enforcement Administration (DEA) guidelines for
prescribing
TEST BANK Pharmacotherapeutics FOR Advanced Practice
4E TEST BANK
, lOMoAR cPSD| 28724214
Contents
Chapter 1 Issues for the Practitioner in Drug Therapy .............................. 3
Chapter 2.Pharmacokinetic Basis of Therapeutics and
Pharmacodynamic .......................................................................................... 5
Chapter 3. Impact of Drug Interactions and Adverse Events on
Therapeutics .................................................................................................. 13
Chapter 4. Principles of Pharmacotherapy in Children ........................... 18
Chapter 5. Principles of Pharmacotherapy in Pregnancy and Lactation
........................................................................................................................ 21
Chapter 6. Principles of Pharmacotherapy in Elderly Patients ............... 27
Chapter 7 Principles of Pharmacotherapy in Pain Management ............ 30
Chapter 8. Principles of Antimicrobial Therapy ....................................... 34
Chapter 9. Complementary and Alternative Medicines ........................... 39
Chapter 10. Pharmacogenomics .................................................................. 43
Chapter 11. Contact Dermatitis.................................................................. 46
Chapter 12. Fungal Infections of the Skin .................................................. 49
Chapter 13 Viral Infections of the Skin ...................................................... 53
Chapter 14 Bacterial Infections of the Skin ............................................... 54
Chapter 15. Psoriasis .................................................................................... 59
Chapter 16. Acne Vulgaris and Rosacea ..................................................... 61
Chapter 17 Ophthalmic Disorders .............................................................. 62
Chapter 18. Otitis Media/Externa ............................................................... 67
Chapter 19. Hypertension ............................................................................ 70
Chapter 20. Hyperlipidemia ........................................................................ 74
Chapter 21. Angina ...................................................................................... 78
Chapter 22. Heart Failure ............................................................................ 83
Chapter 23. Dysrhythmias ........................................................................... 87
Chapter 25. Asthma ..................................................................................... 94
Chapter 26. Chronic Obstructive Pulmonary Disease .............................. 97
Chapter 27. Bronchitis and Pneumonia...................................................... 98
Chapter 28. Nausea and Vomiting ........................................................... 101
, lOMoAR cPSD| 28724214
Chapter 29. Gastroesophageal Reflux Disease and Peptic Ulcer
Disease .......................................................................................................... 103
Chapter 30. Constipation Diarrhea and Irritable Bowel Syndrome ..... 107
Chapter 31 Inflammatory Bowel Disease ................................................. 109
Chapter 32. Urinary Tract Infections ....................................................... 111
Chapter 34. Overactive Bladder ................................................................ 114
Chapter 35. Sexually Transmitted Infections ........................................... 116
Chapter 36. Osteoarthritis and Rheumatoid Arthritis............................ 119
Chapter 37. Fibromyalgia .......................................................................... 121
Chapter 39 Seizure Disorders .................................................................... 127
Chapter 40. Depressive Disorders ............................................................. 131
Chapter 42 Insomnia and Sleep Disorders ............................................... 136
Chapter 43. Attention Deficit/Hyperactivity Disorder ............................ 137
Chapter 44. Alzheimer’s Disease .............................................................. 139
Chapter 45. Diabetes Mellitus.................................................................... 140
Chapter 46. Thyroid Disorders .................................................................. 148
Chapter 47. Allergies and Allergic Reactions ........................................... 152
Chapter 48. Human Immunodeficiency Virus ......................................... 155
Chapter 49. Coagulation Disturbances ..................................................... 158
Chapter 50. Anemias.................................................................................. 161
Chapter 51. Immunizations ....................................................................... 165
Chapter 52. Smoking Cessation................................................................. 169
Chapter 54. Weight Loss ............................................................................ 173
Chapter 55. Contraception......................................................................... 175
Chapter 56. Menopause and Menopausal Hormone Therapy ............... 178
Chapter 57. Osteoporosis ........................................................................... 180
Chapter 58 Vaginitis ................................................................................... 183
Chapter 59. The Economics of Pharmacotherapeutics ........................... 185
Chapter 60. Integrative Approaches to Pharmacotherapy – A look at
Complex Cases ............................................................................................ 189
, lOMoAR cPSD| 28724214
Chapter 1 Issues for the Practitioner in Drug Therapy
MULTIPLE CHOICE
1. Nurse practitioner prescriptive authority is regulated by:
A. The National Council of State Boards of Nursing
B. The U.S. Drug Enforcement Administration
C. The State Board of Nursing for each state
D. The State Board of Pharmacy
ANS: C PTS: 1
2. Physician Assistant (PA) prescriptive authority is regulated by:
A. The National Council of State Boards of Nursing
B. The U.S. Drug Enforcement Administration
C. The State Board of Nursing
D. The State Board of Medical Examiners
ANS: D PTS: 1
3. Clinical judgment in prescribing includes:
A. Factoring in the cost to the patient of the medication prescribed
B. Always prescribing the newest medication available for the disease process
C. Handing out drug samples to poor patients
D. Prescribing all generic medications to cut costs
ANS: A PTS: 1
4. Criteria for choosing an effective drug for a disorder include: A. Asking the
patient what drug they think would work best for them
B. Consulting nationally recognized guidelines for disease management
C. Prescribing medications that are available as samples before writing a
prescription
D. Following U.S. Drug Enforcement Administration (DEA) guidelines for
prescribing
